Mouse Mammary Tumor Virus and Cancer

Part of the Current Cancer Research book series (CUCR)


The retrovirus mouse mammary tumor virus (MMTV) was discovered in the 1930s as a milk-transmitted agent that causes breast cancer in mice. MMTV causes mammary tumors by insertional activation or mutation of cellular oncogenes. Some of the oncogenes activated by MMTV insertion have been also associated with human breast cancer. In addition to allowing the identification of oncogenes associated with this disease, the MMTV long terminal repeat has been used to create numerous strains of transgenic mice with genetic predisposition to breast cancer. Thus, this virus has provided one of the most useful models for understanding human breast cancer.


Lymphoma Lactate Cage Tyrosine Leukemia 


  1. Akagi K, Suzuki T, Stephens RM, Jenkins NA, Copeland NG (2004) RTCGD: retroviral tagged cancer gene database. Nucleic Acids Res 32:D523–D527PubMedCrossRefGoogle Scholar
  2. Arroyo J, Winchester E, McLellan BS, Huber BT (1997) Shared promoter elements between a viral superantigen and the major histocompatibility complex class II-associated invariant chain. J Virol 71:1237–1245PubMedGoogle Scholar
  3. Baillie GJ, van de Lagemaat LN, Baust C, Mager DL (2004) Multiple groups of endogenous betaretroviruses in mice, rats and other mammals. J Virol 78:5784–5798PubMedCrossRefGoogle Scholar
  4. Ball JK, Arthur LO, Dekaban GA (1985) The involvement of type-B retrovirus in the induction of thymic lymphomas. Virology 140:159–172PubMedCrossRefGoogle Scholar
  5. Bhadra S, Lozano MM, Dudley JP (2005) Conversion of mouse mammary tumor virus to a lymphomagenic virus. J Virol 79:12592–12596PubMedCrossRefGoogle Scholar
  6. Bittner JJ (1936) Some possible effects of nursing on the mammary gland tumor incidence in mice. Science 84:162PubMedCrossRefGoogle Scholar
  7. Brekelmans P, van Soest P, Voerman J, Platenburg PP, Leenen PJ et al (1994) Transferrin receptor expression as a marker of immature cycling thymocytes in the mouse. Cell Immunol 159:331–339PubMedCrossRefGoogle Scholar
  8. Broussard DR, Mertz JA, Lozano M, Dudley JP (2002) Selection for c-myc integration sites in polyclonal T-cell lymphomas. J Virol 76:2087–2099PubMedCrossRefGoogle Scholar
  9. Broussard DR, Lozano MM, Dudley JP (2004) Rorgamma (Rorc) is a common integration site in type B leukemogenic virus-induced T-cell lymphomas. J Virol 78:4943–4946PubMedCrossRefGoogle Scholar
  10. Buggiano V, Levy CS, Gattelli A, Cirio MC, Marfil M et al (2002) Origin and progression of pregnancy-dependent mammary tumors induced by new mouse mammary tumor virus variants. Breast Cancer Res Treat 75:191–202PubMedCrossRefGoogle Scholar
  11. Callahan R, Mudunuri U, McCurdy D, Boulanger C, Lowther W et al (submitted) Genes commonly affected by mouse mammary tumor virus (MMTV) proviral insertions are found in primary mammary lesions in mouse and humansGoogle Scholar
  12. Callahan R, Smith GH (2000) MMTV-induced mammary tumorigenesis: gene discovery, progression to malignancy and cellular pathways. Oncogene 19:992–1001PubMedCrossRefGoogle Scholar
  13. Callahan R, Smith GH (2008) Common integration sites for MMTV in viral induced mouse mammary tumors. J Mammary Gland Biol Neoplasia 13:309–321PubMedCrossRefGoogle Scholar
  14. Cardiff RD (2001) Validity of mouse mammary tumour models for human breast cancer: comparative pathology. Microsc Res Tech 52:224–230PubMedCrossRefGoogle Scholar
  15. Cardiff RD (2003) Mouse models of human breast cancer. Comp Med 53:250–253PubMedGoogle Scholar
  16. Cardiff RD, Kenney N (2007) Mouse mammary tumor biology: a short history. Adv Cancer Res 98:53–116PubMedCrossRefGoogle Scholar
  17. Cardiff RD, Wellings SR (1999) The comparative pathology of human and mouse mammary glands. J Mammary Gland Biol Neoplasia 4:105–122PubMedCrossRefGoogle Scholar
  18. Cardiff RD, Anver MR, Gusterson BA, Hennighausen L, Jensen RA et al (2000) The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene 19:968–988PubMedCrossRefGoogle Scholar
  19. Chatterjee G, Rosner A, Han Y, Zelazny ET, Li B et al (2002) Acceleration of mouse mammary tumor virus-induced murine mammary tumorigenesis by a p53 172H transgene: influence of FVB background on tumor latency and identification of novel sites of proviral insertion. Am J Pathol 161:2241–2253PubMedCrossRefGoogle Scholar
  20. Choi YC, Henrard DH, Lee I, Ross SR (1987) The mouse mammary tumor virus long terminal repeat directs expression in epithelial and lymphoid cells of different tissues in transgenic mice. J Virol 61:3013–3019PubMedGoogle Scholar
  21. Coffin JM, Hughes SH, Varmus HE (1997) Retroviruses. CSHL Press, Cold Spring Harbor, NYGoogle Scholar
  22. Dickson C, Smith R, Brookes S, Peters G (1984) Tumorigenesis by mouse mammary tumor virus: proviral activation of a cellular gene in the common integration region int-2. Cell 37:529–536PubMedCrossRefGoogle Scholar
  23. Dievart A, Beaulieu N, Jolicoeur P (1999) Involvement of Notch1 in the development of mouse mammary tumors. Oncogene 18:5973–59781PubMedCrossRefGoogle Scholar
  24. Dion AS, Girardi AJ, Williams CC, Pomenti AA, Redfield ES (1987) Responses of serum from breast cancer patients to murine mammary tumor virus: fact or artifact? J Natl Cancer Inst 79:207–211PubMedGoogle Scholar
  25. Dudley JP (2003) Tag, you’re hit: retroviral insertions identify genes involved in cancer. Trends Mol Med 9:43–45PubMedCrossRefGoogle Scholar
  26. Duesberg PH, Blair PB (1966) Isolation of the nucleic acid of mouse mammary tumor virus (MTV). Proc Natl Acad Sci USA 55:1490–1497PubMedCrossRefGoogle Scholar
  27. Durgam VR, Tekmal RR (1994) The nature and expression of int-5, a novel MMTV integration locus gene in carcinogen-induced mammary tumors. Cancer Lett 87:179–1786PubMedCrossRefGoogle Scholar
  28. Erny KM, Peli J, Lambert JF, Muller V, Diggelmann H (1996) Involvement of the Tpl-2/cot oncogene in MMTV tumorigenesis. Oncogene 13:2015–2020PubMedGoogle Scholar
  29. Finke D, Acha-Orbea H (2001) Differential migration of in vivo primed B and T lymphocytes to lymphoid and non-lymphoid organs. Eur J Immunol 31:2603–2611PubMedCrossRefGoogle Scholar
  30. Ford CE, Tran D, Deng Y, Ta VT, Rawlinson WD et al (2003) Mouse mammary tumor virus-like gene sequences in breast tumors of Australian and Vietnamese women. Clin Cancer Res 9:1118–1120PubMedGoogle Scholar
  31. Gallahan D, Callahan R (1997) The mouse mammary tumor associated gene INT3 is a unique member of the NOTCH gene family (NOTCH4). Oncogene 14:1883–1890PubMedCrossRefGoogle Scholar
  32. Gattelli A, Zimberlin MN, Meiss RP, Castilla LH, Kordon EC (2006) Selection of early-occurring mutations dictates hormone-independent progression in mouse mammary tumor lines. J Virol 80:11409–11415PubMedCrossRefGoogle Scholar
  33. Goedert JJ, Rabkin CS, Ross SR (2006) Prevalence of serologic reactivity against four strains of mouse mammary tumor virus among U.S. women with breast cancer. Br J Cancer 94:548–551PubMedCrossRefGoogle Scholar
  34. Golovkina TV, Prescott JA, Ross SR (1993) Mouse mammary tumor virus-induced tumorigenesis in sag transgenic mice: a laboratory model of natural selection. J Virol 67:7690–7694PubMedGoogle Scholar
  35. Golovkina TV, Piazzon I, Nepomnaschy I, Buggiano V, de Olano VM et al (1997) Generation of a tumorigenic milk-borne mouse mammary tumor virus by recombination between endogenous and exogenous viruses. J Virol 71:3895–3903PubMedGoogle Scholar
  36. Golovkina TV, Dudley JP, Ross SR (1998) Superantigen activity is need for mouse mammary tumor virus spread within the mammary gland. J Immunol 161:2375–2382PubMedGoogle Scholar
  37. Grande SM, Bannish G, Fuentes-Panana EM, Katz E, Monroe JG (2007) Tonic B-cell and viral ITAM signaling: context is everything. Immunol Rev 218:214–234PubMedCrossRefGoogle Scholar
  38. Holmqvist PH, Belikov S, Zaret KS, Wrange O (2005) FoxA1 binding to the MMTV LTR modulates chromatin structure and transcription. Exp Cell Res 304:593–603PubMedCrossRefGoogle Scholar
  39. Imai S, Okumoto M, Iwai M, Haga S, Mori N et al (1994) Distribution of mouse mammary tumor virus in Asian wild mice. J Virol 68:3437–3442PubMedGoogle Scholar
  40. Indik S, Gunzburg WH, Kulich P, Salmons B, Rouault F (2007) Rapid spread of mouse mammary tumor virus in cultured human breast cells. Retrovirology 4:73PubMedCrossRefGoogle Scholar
  41. Jackson RB, Little CC (1933) The existence of non-chromosomal influence in the incidence of mammary tumors in mice. Science 78:465–466PubMedCrossRefGoogle Scholar
  42. Katz E, Lareef MH, Rassa JC, Grande SM, King LB et al (2005) MMTV Env encodes an ITAM responsible for transformation of mammary epithelial cells in three-dimensional culture. J Exp Med 201:431–439PubMedCrossRefGoogle Scholar
  43. Katz E, Dubois-Marshall S, Sims AH, Faratian D, Li J et al (2010) A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of Syk. Br J Cancer 103:401–410PubMedCrossRefGoogle Scholar
  44. Keydar I, Ohno T, Nayak R, Sweet R, Simoni F et al (1984) Properties of retrovirus-like particles produced by a human breast carcinoma cell line: immunological relationship with mouse mammary tumor virus proteins. Proc Natl Acad Sci USA 81:4188–4192PubMedCrossRefGoogle Scholar
  45. Kordon EC, Smith GH (1998) An entire functional mammary gland may comprise the progeny from a single cell. Development 125:1921–1930PubMedGoogle Scholar
  46. Kozak C, Peters G, Pauley R et al (1987) A standardized nomenclature for endogenous mouse mammary tumor viruses. J Virol 61:1651–1654PubMedGoogle Scholar
  47. Kwon BS, Weissman SM (1984) Mouse mammary tumor virus-related sequences in mouse lymphocytes are inducible by 2-O-tetradecanoyl phorbol-13 acetate. J Virol 52:1000–1004PubMedGoogle Scholar
  48. Lasfargues EY, Coutinho WG, Dion AS (1979) A human breast tumor cell line (BT474) that supports mammary tumor virus replication. In Vitro 15:723–728PubMedCrossRefGoogle Scholar
  49. Leder A, Pattengale PK, Kuo A, Stewart TA, Leder P (1986) Consequences of widespread deregulation of the c-myc gene in transgenic mice: multiple neoplasms and normal development. Cell 45:485–495PubMedCrossRefGoogle Scholar
  50. Levine PH, Mesa-Tejada R, Keydar I, Tabbane F, Spiegelman S et al (1984) Increased incidence of mouse mammary tumor virus-related antigen in Tunisian patients with breast cancer. Int J Cancer 33:305–308PubMedCrossRefGoogle Scholar
  51. Li Y, Hively WP, Varmus HE (2000) Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast cancer. Oncogene 19:1002–1009PubMedCrossRefGoogle Scholar
  52. Lowther W, Wiley K, Smith GH, Callahan R (2005) A new common integration site, Int7, for the mouse mammary tumor virus in mouse mammary tumors identifies a gene whose product has furin-like and thrombospondin-like sequences. J Virol 79:10093–10096PubMedCrossRefGoogle Scholar
  53. Luther SA, Maillard I, Luthi F, Scarpellino L, Diggelmann H et al (1997) Early neutralizing antibody response against mouse mammary tumor virus; critical role of viral infection and superantigen-reactive T cells. J Immunol 159:2807–2814PubMedGoogle Scholar
  54. MacArthur CA, Shankar DB, Shackleford GM (1995) Fgf-8, activated by proviral insertion, cooperates with the Wnt-1 transgene in murine mammary tumorigenesis. J Virol 69:2501–2507PubMedGoogle Scholar
  55. Maitra U, Seo J, Lozano MM, Dudley JP (2006) Differentiation-induced cleavage of Cutl1/CDP generates a novel dominant-negative isoform that regulates mammary gene expression. Mol Cell Biol 26:7466–7478PubMedCrossRefGoogle Scholar
  56. Mant C, Gillett C, D’Arrigo C, Cason J (2004) Human murine mammary tumour virus-like agents are genetically distinct from endogenous retroviruses and are not detectable in breast cancer cell lines or biopsies. Virology 318:393–404PubMedCrossRefGoogle Scholar
  57. Marchetti A, Buttitta F, Miyazaki S, Gallahan D, Smith GH et al (1995) Int-6, a highly conserved, widely expressed gene, is mutated by mouse mammary tumor virus in mammary preneoplasia. J Virol 69:1932–1938PubMedGoogle Scholar
  58. McGrath CM (1971) Replication of mammary of mammary tumor virus in tumor cell cultures: dependence on hormone-induced cellular organization. J Natl Cancer Inst 47:455–467PubMedGoogle Scholar
  59. Meyers SL, Dudley JP (1992) Sequence analysis of the int-2/fgf-3 gene in aggressive human breast carcinomas. Mol Carcinog 6:243–251PubMedCrossRefGoogle Scholar
  60. Michalides R (1983) Lymphomagenesis by endogenous mouse mammary tumor virus in the GR mouse strain. In: Westen-Schnurr J (ed) Mechanisms of B cell neoplasia. Editiones Roche-Hoffman La Roche, Basel, pp 196–198Google Scholar
  61. Michalides R, van Deemter L, Nusse R, van Nie R (1978) Identification of the MMTV2 gene responsible for early appearance of mammary tumors in the GR mouse by nucleic acid hybridization. Proc Natl Acad Sci USA 75:2368–2372PubMedCrossRefGoogle Scholar
  62. Mikaelian I, Blades N, Churchill GA, Fancher K, Knowles BB et al (2004) Proteotypic classification of spontaneous and transgenic mammary neoplasms. Breast Cancer Res 6:R668–R679PubMedCrossRefGoogle Scholar
  63. Mink S, Hartig E, Jennewein P, Doppler W, Cato ACB (1992) A mammary cell-specific enhancer in mouse mammary tumor virus DNA is composed of multiple regulatory elements including binding sites for CTF/NF-1 and novel transcription-factor, mammary cell-activating factor. Mol Cell Biol 11:4906–4918Google Scholar
  64. Mok E, Golovkina TV, Ross SR (1992) A mouse mammary tumor virus (MMTV) mammary gland enhancer confers tissue-specific, but not lactation-dependent expression in transgenic mice. J Virol 66:7529–7532PubMedGoogle Scholar
  65. Nandi S, McGrath CM (1973) Mammary neoplasia in mice. Adv Cancer Res 17:353–414CrossRefGoogle Scholar
  66. Nusse R, Varmus HE (1982) Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 31:99–109PubMedCrossRefGoogle Scholar
  67. Nusse R, Van Ooyen A, Cox D, Fung YKT, Varmus HE (1984) Mode of proviral activation of a putative mammary oncogene (int 1) on mouse chromosome 15. Nature 307:131–136PubMedCrossRefGoogle Scholar
  68. Okeoma CM, Ross SR (2010) Genetics of host resistance to retroviruses and cancer. In: Dudley JP (ed) Retroviruses and insights into cancer. Springer Science and Business Media, New York, NYGoogle Scholar
  69. Park DJ, Southey MC, Giles GG, Hopper JL (2011) No evidence of MMTV-like env sequences in specimens from the Australian Breast Cancer Family Study. Breast Cancer Res Treat 125(1):229–235PubMedCrossRefGoogle Scholar
  70. Payvar FP, DeFranco D, Firestone GL, Edgar B, Wrange O et al (1983) Sequence-specific binding of glucocorticoid receptor to MMTV DNA at sites within and upstream of the transcribed region. Cell 35:381–392PubMedCrossRefGoogle Scholar
  71. Ponka P, Lok CN (1999) The transferrin receptor: role in health and disease. Int J Biochem Cell Biol 31:1111–1137PubMedCrossRefGoogle Scholar
  72. Qin W, Golovkina TV, Peng T, Nepomnaschy I, Buggiano V et al (1999) Mammary gland expression of mouse mammary tumor virus is regulated by a novel element in the long terminal repeat. J Virol 73:368–376PubMedGoogle Scholar
  73. Reuss FU, Coffin JM (2000) The mouse mammary tumor virus transcription enhancers for hematopoietic progenitor and mammary gland cells share functional elements. J Virol 74:8183–8187PubMedCrossRefGoogle Scholar
  74. Rosner A, Miyoshi K, Landesman-Bollag E, Liu X, Seldin DC et al (2002) Histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumors. Am J Path 161:1087–1097PubMedCrossRefGoogle Scholar
  75. Ross SR (1997a) MMTV and the immune system. Adv Pharm 39:21–46CrossRefGoogle Scholar
  76. Ross SR (1997b) Mouse mammary tumor virus and the immune system. Adv Pharmacol 39:21–46PubMedCrossRefGoogle Scholar
  77. Ross SR (2000) Using genetics to probe host-virus interactions: the mouse mammary tumor virus model. Microbes Infect 2:1215–1223PubMedCrossRefGoogle Scholar
  78. Ross SR (2010) Mouse mammary tumor virus molecular biology and oncogenesis. Viruses 2:2000–2012. doi: 10.3390/v2092000 PubMedCrossRefGoogle Scholar
  79. Ross SR, Schofield JJ, Farr CJ, Bucan M (2002) Mouse transferrin receptor 1 is the cell entry receptor for mouse mammary tumor virus. Proc Natl Acad Sci USA 99:12386–12390PubMedCrossRefGoogle Scholar
  80. Ross SR, Schmidt JW, Katz E, Cappelli L, Hultine S et al (2006) An immunoreceptor tyrosine activation motif in the mouse mammary tumor virus envelope protein plays a role in virus-induced mammary tumors. J Virol 80:9000–9008PubMedCrossRefGoogle Scholar
  81. Rous P (1911) A sarcoma of the fowl transmissible by an agent separable from the tumor cells. J Exp Med 13:397–411PubMedCrossRefGoogle Scholar
  82. Schroeder JA, Troyer KL, Lee DC (2000) Cooperative induction of mammary tumorigenesis by TGFalpha and Wnts. Oncogene 19:3193–3199PubMedCrossRefGoogle Scholar
  83. Schulman HM, Ponka P, Wilczynska A, Gauthier Y, Shyamala G (1989) Transferrin receptor and ferritin levels during murine mammary gland development. Biochim Biophys Acta 1010:1–6PubMedCrossRefGoogle Scholar
  84. Shackleford GM, MacArthur CA, Kwan HC, Varmus HE (1993) Mouse mammary tumor virus infection accelerates mammary carcinogenesis in Wnt1 transgenic mice by insertional activation of int2/Fgf3 and hst/Fgf4. Proc Natl Acad Sci USA 90:740–744PubMedCrossRefGoogle Scholar
  85. Squartini F, Basolo F, Bistocchi M (1983) Lobuloalveolar differentiation and tumorigenesis: two separate activities of mouse mammary tumor virus. Cancer Res 43:5879–5882PubMedGoogle Scholar
  86. Stewart TA, Pattengale PK, Leder P (1984) Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MMTV/myc fusion genes. Cell 38:627–637PubMedCrossRefGoogle Scholar
  87. Suzuki T, Shen H, Akagi K, Morse HC, Malley JD et al (2002) New genes involved in cancer identified by retroviral tagging. Nat Genet 32:166–174PubMedCrossRefGoogle Scholar
  88. Theodorou V, Boer M, Weigelt B, Jonkers J, van der Valk M et al (2004) Fgf10 is an oncogene activated by MMTV insertional mutagenesis in mouse mammary tumors and overexpressed in a subset of human breast carcinomas. Oncogene 23:6047–6055PubMedCrossRefGoogle Scholar
  89. Theodorou V, Kimm MA, Boer M, Wessels L, Theelen W et al (2007) MMTV insertional mutagenesis identifies genes, gene families and pathways involved in mammary cancer. Nat Genet 39:759–769PubMedCrossRefGoogle Scholar
  90. Vicent GP, Zaurin R, Nacht AS, Font-Mateu J, Le Dily F et al (2010) Nuclear factor 1 synergizes with progesterone receptor on the mouse mammary tumor virus promoter wrapped around a histone H3/H4 tetramer by facilitating access to the central hormone-responsive elements. J Biol Chem 285:2622–2631PubMedCrossRefGoogle Scholar
  91. Wagner KU, McAllister K, Ward T, Davis B, Wiseman R et al (2001) Spatial and temporal expression of the Cre gene under the control of the MMTV-LTR in different lines of transgenic mice. Transgenic Res 10:545–553PubMedCrossRefGoogle Scholar
  92. Wang Y, Holland JF, Bleiweiss IJ, Melana S, Liu X et al (1995) Detection of mammary tumor virus ENV gene-like sequences in human breast cancer. Cancer Res 35:5173–5179Google Scholar
  93. Wang E, Obeng-Adjei N, Ying Q, Meertens L, Dragic T et al (2008) Mouse mammary tumor virus uses mouse but not human transferrin receptor 1 to reach a low pH compartment and infect cells. Virology 381:230–240PubMedCrossRefGoogle Scholar
  94. Yanagawa SI, Kakimi K, Tanaka H, Murakami A, Nakagawa Y et al (1993) Mouse mammary tumor virus with rearranged long terminal repeats causes murine lymphomas. J Virol 67:112–118PubMedGoogle Scholar
  95. Yanagawa S, Lee JS, Kakimi K, Matsuda Y, Honjo T et al (2000) Identification of Notch1 as a frequent target for provirus insertional mutagenesis in T-cell lymphomas induced by leukemogenic mutants of mouse mammary tumor virus. J Virol 74:9786–9791PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Department of Microbiology, Abramson Cancer CenterUniversity of Pennsylvania School of MedicinePhiladelphiaUSA

Personalised recommendations